Cargando…
Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract
As a result of the high approval dynamics and the growing number of immuno-oncological concepts, the complexity of treatment decisions and control in the area of cancers of the esophagus, gastroesophageal junction and stomach is constantly increasing. Since the treatment indication for PD-1 inhibito...
Autores principales: | Baretton, Gustavo B., Lordick, Florian, Gaiser, T., Hofheinz, R., Horst, D., Lorenzen, S., Moehler, M., Röcken, C., Schirmacher, P., Stahl, M., Thuss-Patience, P., Tiemann, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620316/ https://www.ncbi.nlm.nih.gov/pubmed/37874352 http://dx.doi.org/10.1007/s00432-023-05180-5 |
Ejemplares similares
-
HER2 testing in gastric cancer: results of a German expert meeting
por: Lordick, Florian, et al.
Publicado: (2017) -
EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
por: Wagner, Anna Dorothea, et al.
Publicado: (2019) -
Upper gastrointestinal tract bleeding in the ICU
por: Araujo, P, et al.
Publicado: (2009) -
Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer
por: Lordick, Florian, et al.
Publicado: (2023) -
Intramural Pseudocysts of the Upper Gastrointestinal Tract
por: Rana, Surinder Singh, et al.
Publicado: (2013)